BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19829006)

  • 1. Future target molecules in antiglaucoma therapy: tgf-Beta may have a role to play.
    Agarwal R; Agarwal P
    Ophthalmic Res; 2010; 43(1):1-10. PubMed ID: 19829006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
    Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What increases outflow resistance in primary open-angle glaucoma?
    Tamm ER; Fuchshofer R
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S101-4. PubMed ID: 17998032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trabecular meshwork as a new target for the treatment of glaucoma.
    Ferrer E
    Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?
    Agarwal P; Agarwal R
    Expert Opin Ther Targets; 2018 Jul; 22(7):629-638. PubMed ID: 29883239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Transforming Growth Factor-β Signaling in Primary Open-Angle Glaucoma.
    Wang J; Harris A; Prendes MA; Alshawa L; Gross JC; Wentz SM; Rao AB; Kim NJ; Synder A; Siesky B
    J Glaucoma; 2017 Apr; 26(4):390-395. PubMed ID: 28169917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
    Zhao X; Ramsey KE; Stephan DA; Russell P
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transforming growth factor-beta1 induced cultured human trabecular cells to produce elastin].
    Zhong L; Li M
    Zhonghua Yan Ke Za Zhi; 1999 Sep; 35(5):383-5. PubMed ID: 11835846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in understanding the pathophysiology of elevated intraocular pressure.
    Tan JC; Peters DM; Kaufman PL
    Curr Opin Ophthalmol; 2006 Apr; 17(2):168-74. PubMed ID: 16552252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of transforming growth factor β in glaucoma and the therapeutic implications.
    Prendes MA; Harris A; Wirostko BM; Gerber AL; Siesky B
    Br J Ophthalmol; 2013 Jun; 97(6):680-6. PubMed ID: 23322881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.
    Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of TGF-β in the pathogenesis of primary open-angle glaucoma.
    Fuchshofer R; Tamm ER
    Cell Tissue Res; 2012 Jan; 347(1):279-90. PubMed ID: 22101332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue.
    Clark AF; Brotchie D; Read AT; Hellberg P; English-Wright S; Pang IH; Ethier CR; Grierson I
    Cell Motil Cytoskeleton; 2005 Feb; 60(2):83-95. PubMed ID: 15593281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of excess synthesis of extracellular matrix components by trabecular meshwork cells: possible consequence on aqueous outflow.
    Tane N; Dhar S; Roy S; Pinheiro A; Ohira A; Roy S
    Exp Eye Res; 2007 May; 84(5):832-42. PubMed ID: 17350618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matricellular proteins in the trabecular meshwork.
    Rhee DJ; Haddadin RI; Kang MH; Oh DJ
    Exp Eye Res; 2009 Apr; 88(4):694-703. PubMed ID: 19101543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in glaucoma diagnosis and therapy for the next millennium: new drugs for trabecular and uveoscleral outflow.
    Kaufman PL; Gabelt B; Tian B; Liu X
    Semin Ophthalmol; 1999 Sep; 14(3):130-43. PubMed ID: 10790577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of extracellular matrix turnover in the trabecular meshwork.
    Fuchshofer R; Tamm ER
    Exp Eye Res; 2009 Apr; 88(4):683-8. PubMed ID: 19385040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats.
    Robertson JV; Golesic E; Gauldie J; West-Mays JA
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):308-18. PubMed ID: 19696167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor: Role in trabecular meshwork remodeling and intraocular pressure lowering.
    Hassan MDS; Razali N; Abu Bakar AS; Abu Hanipah NF; Agarwal R
    Exp Biol Med (Maywood); 2023 Aug; 248(16):1425-1436. PubMed ID: 37873757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix Metalloproteinases and Glaucoma Treatment.
    Weinreb RN; Robinson MR; Dibas M; Stamer WD
    J Ocul Pharmacol Ther; 2020 May; 36(4):208-228. PubMed ID: 32233938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.